Protecting Kids from Pneumonia Salisbury MD

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule) in Salisbury.

Dr. Marcus Sidney Shaker
Salisbury, MD
Specialty
Pediatrics

Mohsin Ansari, MD
(410) 742-0770
106 Pine Bluff Rd Ste 11
Salisbury, MD
Specialties
Pediatrics, Neonatal-Perinatal Medicine
Gender
Male
Education
Medical School: Dow Med Coll, Univ Of Karachi, Karachi, Pakistan
Graduation Year: 1989

Data Provided by:
Lucy Y Evangelista
(410) 543-2362
105 Pine Bluff Rd
Salisbury, MD
Specialty
Pediatrics

Data Provided by:
William Anthony Strott
(410) 749-8300
1205 Pemberton Dr
Salisbury, MD
Specialty
Pediatrics

Data Provided by:
Dr. Hirut Felleke Degefu
Salisbury, MD
Specialty
Pediatrics

Morgan James MD
(410) 546-5722
560 Riverside Drive Suite B204
Salisbury, MD
 
A Kimberly Iafolla, MD, FAAP
(410) 543-7198
100 E Earroll ST
Salisbury, MD
Specialties
Pediatrics
Gender
Male
Education
Graduation Year: 1984

Data Provided by:
Dr. Lucy Y Evangelista
105 Pine Bluff Rd Ste 4
Salisbury, MD
Specialty
Pediatrics

Sharon Andrea McFayden Eyo
(410) 749-8300
1205 Pemberton
Salisbury, MD
Specialty
Pediatrics

Data Provided by:
Saroja Revanna Barhan, MD
(410) 968-2111
Salisbury, MD
Specialties
Pediatrics, Neonatal-Perinatal Medicine
Gender
Female
Education
Medical School: Mysore Med Coll, Mysore Univ, Mysore, Karnataka, India
Graduation Year: 1963

Data Provided by:
Data Provided by:

Protecting Kids from Pneumonia

Provided By:

Parents and babies alike will be relieved by new findings that show a reduced-dose schedule for the pneumococcal vaccine can protect infants against pneumonia and other infections.

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule). But factors such as questions about the cost-effectiveness of the current PCV-7 dose schedule have led researchers to examine reduced-dose vaccine schedules, according to background information in the study.

The researchers, Dr. Elske J.M. van Gils, of the University Medical Center Utrecht in the Netherlands, and colleagues, studied 1,003 healthy infants who were randomly assigned to receive two doses of PCV-7 at 2 months and 4 months of age, or a 2 + 1-dose schedule at 2, 4 and 11 months of age, or no vaccine (control group). The children were checked after 12 months, 18 months and 24 months for pneumococcal microorganisms in the upper part of the throat behind the nose.

Compared to those in the control group, children in both vaccine groups had far lower rates of microorganisms that can cause pneumonia and other infections, according to the report in the July 8 issue of the Journal of the American Medical Association.

"In conclusion, both two-dose and 2 + 1-dose schedules of PCV-7 significantly reduce vaccine serotype pneumococcal carriage in children. This study supports future implementation of reduced-dose PCV-7 schedules," the researchers concluded.

More information

The Nemours Foundation has more about children and pneumonia.

SOURCE: Journal of the American Medical Association, news release, July 7, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com